Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 1761 - 1768 of 12093 results
Mintz Adds Troutman Pepper Partner To Expand PE Practice
April 25, 2023| News
CMS Issues Updated Guidance for Home Dialysis Provided at Nursing Homes
April 25, 2023| Blog| Viewpoint
Health Law Diagnosed – EnforceMintz – Part 2: DOJ Regulatory and Policy Update
April 25, 2023| Podcast| Viewpoint
From the Edge - In the Boardroom: Special Edition - Lessons Learned from Silicon Valley Bank
April 24, 2023| Podcast| Viewpoint
BEA Reporting Requirements: Have You Reported Your Cross-Border Investments?
April 21, 2023| Advisory| Viewpoint
District Courts Will Hear Constitutional Challenges to SEC and FTC Admin Courts
April 19, 2023| Blog| Viewpoint
The Inflation Reduction Act of 2022: Takeaways for the Clean Energy Sector
April 19, 2023| Blog| Viewpoint
Mintz Co-Hosts Annual Pro Bono Clinic for Nonprofits with ACC-NE
April 19, 2023| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|